Evidence map›Paper›PMID 39302476›Full record

ArticleNanomedicine (London, England)2024

Biodegradable hafnium-doped CaCO

Min-Hua Chen, Xiang-Hao Zeng, Yi-Ting Shu, Hsiang-Kuang Liang, Ching-Yun Chen, Chun-Yu Lin, Cheng-An J Lin, Jen-Kun Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomedicine (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Min-Hua ChenDepartment of Biomedical Engineering, Chung Yuan Christian University, Taoyuan City, 320314, Taiwan.ORCID 0000-0003-0513-1301
Xiang-Hao ZengDepartment of Biomedical Engineering, Chung Yuan Christian University, Taoyuan City, 320314, Taiwan.
Yi-Ting ShuDepartment of Biomedical Engineering, Chung Yuan Christian University, Taoyuan City, 320314, Taiwan.
Hsiang-Kuang LiangDepartment of Biomedical Engineering, National Taiwan University, Taipei City, 10617, Taiwan.
Ching-Yun ChenInstitute of Biomedical Engineering & Nanomedicine, National Health Research Institutes, Miaoli County, 35053, Taiwan.
Chun-Yu LinDepartment of Biomedical Engineering, Chung Yuan Christian University, Taoyuan City, 320314, Taiwan.
Cheng-An J LinDepartment of Biomedical Engineering, Chung Yuan Christian University, Taoyuan City, 320314, Taiwan.ORCID 0000-0002-0452-1132
Jen-Kun ChenInstitute of Biomedical Engineering & Nanomedicine, National Health Research Institutes, Miaoli County, 35053, Taiwan.ORCID 0000-0002-3433-5971

Funding

National Health Research Institutes (NHRI) NHRI-BN-112-PP31National Science and Technology Council 110-2222-E-033-003-MY3, 112-2622-E-033-007
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Calcium CarbonateHafniumNanoparticlesRadiation-Sensitizing AgentsCell Line, TumorCell SurvivalHumansHydrogen-Ion ConcentrationNeoplasmsCalcium CarbonateHafniumRadiation-Sensitizing Agentsbioceramicscancer/oncologynanomaterialsnanoparticlestherapeutics

Identifiers

PMID39302476
PMCPMC11418210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.